ProShare Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.3M | Buy |
|
|||||
|
2025
Q1 | $57.7M | Buy |
|
|||||
|
2024
Q4 | $45.1M | Buy |
|
|||||
|
2024
Q3 | $45.2M | Buy |
|
|||||
|
2024
Q2 | $41.3M | Sell |
|
|||||
|
2024
Q1 | $41.2M | Buy |
|
|||||
|
2023
Q4 | $32.8M | Sell |
|
|||||
|
2023
Q3 | $39.1M | Buy |
|
|||||
|
2023
Q2 | $35.7M | Sell |
|
|||||
|
2023
Q1 | $37.8M | Buy |
|
|||||
|
2022
Q4 | $34.7M | Sell |
|
|||||
|
2022
Q3 | $31.3M | Sell |
|
|||||
|
2022
Q2 | $44M | Sell |
|
|||||
|
2022
Q1 | $64.4M | Buy |
|
|||||
|
2021
Q4 | $4.97M | Buy |
|
|||||
|
2021
Q3 | $4.01M | Buy |
|
|||||
|
2021
Q2 | $3.84M | Buy |
|
|||||
|
2021
Q1 | $3.16M | Sell |
|
|||||
|
2020
Q4 | $3.77M | Buy |
|